Double Agent –
March 20, 2019 – Purdue Pharma, the maker of the opioid painkiller OxyContin, is one of the opioid companies being sued by more than 1,600 cities and counties for “grossly” misrepresenting “the risks of long-term use of those drugs for persons with chronic pain,” according to court documents. The lawsuits have been consolidated into one case in federal court in Cleveland. Purdue vigorously denies allegations that it deceptively marketed OxyContin. Ashley spent three decades at the DEA, specializing in preventing the diversion of prescription drugs like OxyContin. Reached by NBC News on her cellphone in Chicago, Ashley said, “I have been consulting for members of the industry and I began my consulting business in June 2018 after I retired.” Ashley said she could not confirm or deny who her clients are unless “they say it’s OK.”
